DC

David T. Curiel

TF The Uab Research Foundation: 29 patents #2 of 813Top 1%
Genentech: 6 patents #494 of 2,392Top 25%
BO BOE: 6 patents #3,067 of 12,373Top 25%
UH University Of North Carolina At Chapel Hill: 4 patents #169 of 1,688Top 15%
TC The University Of Chicago: 2 patents #279 of 1,377Top 25%
CH City Of Hope: 2 patents #175 of 524Top 35%
UB University Of Alabama At Birmingham: 2 patents #1 of 34Top 3%
SG Selective Genetics: 1 patents #10 of 17Top 60%
UC University Of North Carolina: 1 patents #81 of 213Top 40%
WU Washington University: 1 patents #704 of 1,596Top 45%
University Of Texas System: 1 patents #2,951 of 6,559Top 45%
📍 Saint Louis, MO: #4 of 229 inventorsTop 2%
🗺 Missouri: #234 of 23,789 inventorsTop 1%
Overall (All Time): #79,015 of 4,157,543Top 2%
40
Patents All Time

Issued Patents All Time

Showing 1–25 of 40 patents

Patent #TitleCo-InventorsDate
11542526 Oncolytic adenoviral vector and methods of use Osvaldo Podhajcer, Maria Veronica Lopez 2023-01-03
10709745 Tropic cell based virotherapy for the treatment of cancer Karen Aboody, Alexander J. Annala, Maciej S. Lesniak 2020-07-14
10391183 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof Juan Fueyo-Margareto, Candelaria Gomez-Manzano 2019-08-27
10238699 Tropic cell based virotherapy for the treatment of cancer Karen Aboody, Alexander J. Annala, Maciej S. Lesniak 2019-03-26
9267153 Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection 2016-02-23
7297542 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob Victor Krasnykh, Igor Dmitriev 2007-11-20
7045127 Human anti-epidermal growth factor receptor single-chain antibodies Kevin Raisch, James Bonner 2006-05-16
6955808 Capsid-modified recombinant adenovirus and methods of use 2005-10-18
6841540 Immunomodulation by genetic modification of dendritic cells and B cells Bryan W. Tillman 2005-01-11
6824771 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof Victor Krasnykh, Ramon Alemany, Igor Dmitriev 2004-11-30
6815200 Modified adenovirus containing a fiber replacement protein Victor Krasnykh 2004-11-09
6716622 Tissue-specific self-inactivating gene therapy vector Paul Reynolds 2004-04-06
6716823 Noninvasive genetic immunization, expression products therefrom, and uses thereof De-Chu C. Tang, Donald H. Marks, Zhongkai Shi 2004-04-06
6706693 Vaccination by topical application of genetic vectors De-Chu C. Tang, Donald H. Marks, Zhongkai Shi 2004-03-16
6699473 Human anti-epidermal growth factor receptor single-chain antibodies Kevin Raisch, James Bonner 2004-03-02
6689605 Controlling immune response to specific antigens John D. Mountz, Huang-Ge Zhang 2004-02-10
6683170 Ligands added to adenovirus fiber Jeffrey Engler 2004-01-27
6649396 Fiber receptor-independent system for the propagation of adenoviral vectors Igor Dmitriev, Victor Krasnykh, Joanne Douglas 2003-11-18
6613563 Viral vectors with modified tropism Barbara A. Sosnowski, Andrew Baird, Glenn Pierce, Joanne Douglas, Buck Rogers 2003-09-02
6599909 Molecular chemotherapy enhancement of radiotherapy Donald J. Buchsbaum, Murray Stackhouse, Lee C. Pederson 2003-07-29
6555368 Capsid-modified recombinant adenovirus and methods of use 2003-04-29
6468547 Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies Donald J. Buchsbaum, Murray Stackhouse 2002-10-22
6436393 Adenoviral vector encoding anti-apoptotic Bcl-2 gene and uses thereof Guadalupe Bilbao, Juan Contreras 2002-08-20
6348450 Noninvasive genetic immunization, expression products therefrom and uses thereof De-Chu C. Tang, Donald H. Marks, Zhongkai Shi, Kent R. Van Kampen 2002-02-19
6333030 Chimeric retrovirus/adenovirus system 2001-12-25